Literature DB >> 1875017

1,25-Dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein).

M Petrini1, A Azzarà, G Carulli, B Grassi, F Ambrogi, R M Galbraith.   

Abstract

The identification of Gc (vitamin D binding protein) with the anionic polypeptide cochemotaxin has recently been reported. In this paper we investigate its dose dependent cochemotactic activity and report the inhibition of Gc enhanced chemotaxis by vitamin D3. These results further support the role of immunomodulating hormone played by vitamin D.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1875017     DOI： 10.1007/BF03349090

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  27 in total

1.  Measurement of 25-hydroxyvitamin D3 in serum.

Authors:  R Bouillon; P V Kerkhove; P De Moor
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

2.  Phenotypic markers in chronic lymphocytic leukemia.

Authors:  M Petrini; G Carulli; F Ambrogi; R M Galbraith
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

3.  Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein).

Authors:  M H Williams; E L Van Alstyne; R M Galbraith
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

4.  Structural studies of T lymphocyte Fc receptors. Association of Gc protein with IgG binding to Fc gamma.

Authors:  M Petrini; R M Galbraith; D L Emerson; A E Nel; P Arnaud
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

5.  Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein.

Authors:  M Petrini; D L Emerson; R M Galbraith
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

6.  1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation.

Authors:  W C Chen; B Vayuvegula; S Gupta
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

Review 7.  1,25-Dihydroxyvitamin D3 and the immune system.

Authors:  S C Manolagas; F G Hustmyer; X P Yu
Journal:  Proc Soc Exp Biol Med       Date:  1989-07

8.  1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone.

Authors:  C D Tsoukas; D M Provvedini; S C Manolagas
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

9.  1,25-dihydroxyvitamin D3 receptors in human leukocytes.

Authors:  D M Provvedini; C D Tsoukas; L J Deftos; S C Manolagas
Journal:  Science       Date:  1983-09-16       Impact factor: 47.728

10.  Vitamin D-binding protein (Gc-globulin) binds actin.

Authors:  H Van Baelen; R Bouillon; P De Moor
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157
View more
  4 in total

1.  Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.

Authors:  Anisha B Shah; Stephen J DiMartino; Glenda Trujillo; Richard R Kew
Journal:  Mol Immunol       Date:  2005-08-22       Impact factor: 4.407

2.  Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules.

Authors:  Stephen J DiMartino; Glenda Trujillo; Lauren A McVoy; Jianhua Zhang; Richard R Kew
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

3.  Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.

Authors:  Glenda Trujillo; Jianhua Zhang; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard R Kew
Journal:  Mol Immunol       Date:  2011-10-19       Impact factor: 4.407

4.  Neutrophil recruitment to the lung in both C5a- and CXCL1-induced alveolitis is impaired in vitamin D-binding protein-deficient mice.

Authors:  Glenda Trujillo; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Nancy E Cooke; Richard R Kew
Journal:  J Immunol       Date:  2013-06-10       Impact factor: 5.422
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.